RE: Ft article 3 hrs ago1 May 2025 19:37
None of this would be of great concern if THG delivered cash. But THG’s cash outflow last year was £88mn.
The idea behind its disposal in December of Ingenuity, the loss-making online marketing and logistics division, was to reset the business around its slower-growing but profitable nutrition and cosmetics operations while bringing debt down to manageable levels. However, excluding Ingenuity, 2024 group free cash flow was only just neutral at £400,000.
THG asks investors to also exclude one-offs, which is how it arrives at an underlying-underlying hypothetical remainco cash flow for 2024 of £21.6mn. Problem is, underlying-underlying hypothetical cash flow doesn’t pay the bills, which remain high even by management’s preferred measures: gross debt of £400mn at the 2024 year-end was equivalent to 3.8 times adjusted remainco Ebitda.
Cash flow improvement this year relies largely on whey prices easing. It’s a bit of a gamble.
The performance of nutrition at THG seems to get buffeted by whey costs much more than at Glanbia, a London-listed peer, says Panmure-Liberum’s Brown. Some of that may reflect disruption from a recent rebrand of THG’s Myprotein and some loss of competitiveness in Japan due to sterling’s strength against the yen — though, again, investors may think twice about treating these factors as one-off.
Glanbia’s protein shake division shrugged off record-high input prices in 2024 to deliver a 16.9 per cent margin. THG Nutrition’s margin more than halved to just 6 per cent. That’s in spite of THG products tending to be made with Whey Protein Concentrate, which is less volatile (and cheaper) than Whey Protein Isolate, which Glanbia favours.
Some of the earnings unpredictability is because, unlike Glanbia, THG prefers short-term supply agreements, Brown tells clients:
The situation raises broader questions regarding the strength of the Myprotein brand, the robustness of the company’s revenue management strategies, and the effectiveness of its brand and supply chain management. [ . . . ] Notably, despite two major whey price shocks in the past three years, there is little evidence that THG has adjusted its procurement strategy — such as securing longer-term contracts — to better manage input volatility.